Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
Total Valuation
NeuroOne Medical Technologies has a market cap or net worth of $44.99M. The enterprise value is $29.25M.
Market Cap$44.99M
Enterprise Value$29.25M
Share Statistics
NeuroOne Medical Technologies has 50,413,147 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,413,147
Owned by Insiders11.42%
Owned by Institutions21.62%
Financial Efficiency
NeuroOne Medical Technologies’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -49.83%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.33
Return on Invested Capital (ROIC)-49.83%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee711.63K
Profits Per Employee-212.08K
Employee Count17
Asset Turnover0.84
Inventory Turnover1.78
Valuation Ratios
The current PE Ratio of NeuroOne Medical Technologies is ―. NeuroOne Medical Technologies’s PEG ratio is 0.12.
PE Ratio―
PS Ratio3.92
PB Ratio5.04
Price to Fair Value5.04
Price to FCF-12.22
Price to Operating Cash Flow-10.39
PEG Ratio0.12
Income Statement
In the last 12 months, NeuroOne Medical Technologies had revenue of 12.10M and earned -3.61M in profits. Earnings per share was -0.09.
Revenue12.10M
Gross Profit8.14M
Operating Income-4.23M
Pretax Income-3.61M
Net Income-3.61M
EBITDA-3.01M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -2.84M and capital expenditures -81.74K, giving a free cash flow of -2.92M billion.
Operating Cash Flow-2.84M
Free Cash Flow-2.92M
Free Cash Flow per Share-0.06
Dividends & Yields
NeuroOne Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.73
52-Week Price Change-20.36%
50-Day Moving Average0.72
200-Day Moving Average0.74
Relative Strength Index (RSI)61.57
Average Volume (3m)532.45K
Important Dates
NeuroOne Medical Technologies upcoming earnings date is Feb 17, 2026, Before Open (Confirmed).
Last Earnings DateDec 17, 2025
Next Earnings DateFeb 17, 2026
Ex-Dividend Date―
Financial Position
NeuroOne Medical Technologies as a current ratio of 4.44, with Debt / Equity ratio of 2.02%
Current Ratio4.44
Quick Ratio3.47
Debt to Market Cap<0.01
Net Debt to EBITDA1.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NeuroOne Medical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroOne Medical Technologies EV to EBITDA ratio is -6.92, with an EV/FCF ratio of -10.02.
EV to Sales3.22
EV to EBITDA-6.92
EV to Free Cash Flow-10.02
EV to Operating Cash Flow-10.31
Balance Sheet
NeuroOne Medical Technologies has $6.57M in cash and marketable securities with $266.81K in debt, giving a net cash position of $6.30M billion.
Cash & Marketable Securities$6.57M
Total Debt$266.81K
Net Cash$6.30M
Net Cash Per Share$0.13
Tangible Book Value Per Share$0.18
Margins
Gross margin is 56.51%, with operating margin of -46.46%, and net profit margin of -39.63%.
Gross Margin56.51%
Operating Margin-46.46%
Pretax Margin-39.63%
Net Profit Margin-39.63%
EBITDA Margin-46.46%
EBIT Margin0.00%
Analyst Forecast
The average price target for NeuroOne Medical Technologies is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.00
Price Target Upside322.54% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast250.35%
EPS Growth Forecast83.06%